Rochester Clinical Research is currently enrolling adults in a new smoking cessation research study. This trial is designed to evaluate new investigational approaches that could help people successfully quit smoking for good.
Recently Quit Smoking Study
Age Range:
18 to 75
Gender:
Male and Female
Location:
Rochester, New York
About the Study
Every cigarette contains a deadly mix of 7,000 chemicals, including hundreds that are harmful and about 70 known to cause cancer. According to the CDC, tobacco use causes more than 480,000 deaths in the U.S. each year — including 41,000 from secondhand smoke exposure.
If you’ve recently quit smoking or are ready to quit soon, you may be eligible to join a research study to help people stay smoke-free for good.
Rochester Clinical Research is currently enrolling adults in a research study assessing if individuals who recently quit, or willing to quit within a week of their first visit decrease their risk of relapse to cigarette smoking in adults who recently quit. The study will last approximately 34 weeks with 10 visits to our office and 6 “zoom” visits. There is a 33% chance of placebo.
Qualifications
You may qualify if you:
- You may qualify if you:
- Are between 18 and 75 years old
- Have smoked more than 10 cigarettes per day before quitting
- Have recently quit smoking or are willing to quit within one week of your first visit
- Are willing to attend all study visits
Please note, other conditions may apply.
FEATURED STUDIES
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]